|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Foreign direct investment spillovers and technical efficiency in the Indonesian pharmaceutical sector: firm level evidence显示文摘 | Suyanto Ruhul Salim | 2013 | Applied Economics2013，，3： | 2 |
| 2 | Operating history of Arun Iiquefied Natural Gas Plant显示文摘 | OEKON J R SUYANTO P T | 1985 | Journal of Petroleum Technology1985，37，5： | 1 |
| 3 | Foreign direet investment spillovers and technical efficiency in the Indonesian pharmaceutical sector: firm level evidence显示文摘 | Suyanto Salim R | 2013 | Applied Economics2013，45，3： | 1 |
| 4 | Implications of Uncertainty and Scale in Carbon Emission Estimates on Locally Appropriate Designs to Reduce Emissions from Deforestation and Degradation( REDD + ) 显示文摘 | Lusiana B van Noordwijk M Johana F Galudra G Suyanto S Cadisch G | 2014 | Mitigation and Adaptation Strategies for Global Change2014，19，6： | 1 |
| 5 | A national survey of neonatal peripherally inserted central catheter (PICC) prac- tices 显示文摘 | Jobiliong E Suyanto H Marpaung A M | 2013 | Adv Neonatal Care2013，13，1： | 1 |
| 6 | Foreign Direct Investment Spillovers and Tech- nical Efficiency in the Indonesian Pharmaceutical Sector: Firm Lev- el Evidence 显示文摘 | Suyanto Salim R | 2013 | Applied Economics2013，，45： | 1 |
| 7 | Evolutionary discrete firefly algorithm for travelling salesman problem 显示文摘 | Jati Gilang Kusuma Suyanto | 2011 | Adaptive and Intelligent Systems2011，6943，： | 1 |
| 8 | Bats of the Sangkulirang limestone karst formations,East Kalimantan-a priority region for Bornean bat conservation显示文摘 | SUYANTO A STRUEBIG M J | 2007 | Acta Chiropterologica2007，9，1： | 1 |
| 9 | Foreign direct investment spillovers and technical efficiency in the Indonesianpharmaceutical sector: firm level evidence显示文摘 | Suyanto Salim R | 2013 | Applied Economics2013，45，3： | 1 |
| 10 | Which Firms Benefit from Foreign Direct Investment?Empirical Evidence from Indonesian Manufacturing显示文摘 | Suyanto Ruhul Salim Harry Bloch | 2014 | Journal of Asian Economics2014，33，： | 1 |
| 11 | A model for periodic vehicle routing problem with delivery and pick-up considering maximum dis- tance显示文摘 | Suyanto C Herman M | 2014 | International Journal of Science and Advanced Technology2014，4，8： | 1 |
| 12 | Evolution of land tenure institutions and development of agroforestry: Evidence from customary land areas of Sumatra显示文摘 | Otsuka K Suyanto S Sonobe T | 2001 | Agricultural Economics2001，25，1： | 1 |
| 13 | Sources of Productivity gains from FDI in Indonesia:Is it efficiency improvement or technological progress显示文摘 | Suyanto Ruhul A.Salim | | 0，，04： | 1 |
| 14 | Auto tuning valve positioner on process control training (PCT) base on PC 显示文摘 | Soehartanto T Kaustar L Suyanto | 2002 | IEEE Circuits and Systems2002，，2： | 1 |
| 15 | Sources of productivity gains from FDI in indonesia: Is it efficiency improvement or technological progress? 显示文摘 | SUYANTO RUHUL A S | 2010 | The developing economies2010，，4： | 1 |
| 16 | Individualized therapy for metastatic renal cell carcinoma显示文摘Metastatic Renal Cell Carcinoma(mRCC)is a highly heterogeneous disease that is notoriously difficult to treat successfully.However,the discovery of novel,targeted therapies over the last decade has revolutionized its management.As the therapeutic options continue to evolve,developing a more individualized treatment strategy is of paramount importance.The International mRCC Database Consortium(IMDC)is a prognostic model that is commonly used in trials and clinical settings to risk stratify patients.This allows for optimal therapy selection on a more individual basis.However,the distinct lack of validated predictive biomarkers in mRCC renders it difficult to assess therapy response.An improved understanding of tumor biology and genetics has prompted a shift from cytokine therapy to the use of vascular endothelial growth factor(VEGF)inhibitors,tyrosine kinase Inhibitors,immune checkpoint inhibitors or combination strategies.Studies have identified some putative markers and genetic mutations as potential predictors of therapy response.Early results are promising,and there are many ongoing trials further assessing their suitability for clinical use.This review will evaluate the current treatment landscape and molecular biology of mRCC,with a specific focus on the prognostic and predictive markers available to guide treatment options and further improve patient outcomes. | Bambang T.Atmaja Izabelle Wood Suyanto Suyanto Paramvir Sawhney Agnieszka Michael Hardev Pandha | 2021 | Journal of Cancer Metastasis and Treatment2021，7，1： | 0 |
| 17 | Adjuvant therapy for renal cell carcinoma显示文摘Recent advances in the treatment of metastatic renal cell carcinoma expose a gap in the treatment of less advanced,localized disease.Tyrosine kinase inhibitors,which revolutionized the treatment of metastatic disease,have not provided a similar survival benefit in the adjuvant setting and currently only sunitinib is approved by the Food and Drug Administration for adjuvant treatment in patients with high-risk of recurrence based on S-TRAC disease-free survival data.The advent of immune checkpoint inhibitors has offered a fresh hope in the field of adjuvant treatment after encouraging results are seen with combination of immune checkpoint inhibitors as well as with targeted therapy in the metastatic setting.Several studies are investigating these combinations in the adjuvant setting,and it is hoped that they will bring about a better outcome for a largely unmet need in kidney cancer treatment. | Paramvir Sawhney Suyanto Suyanto Agnieszka Michael Hardev Pandha | 2021 | Journal of Cancer Metastasis and Treatment2021，7，1： | 0 |
| 18 | The Factors Affecting Profit Distribution: An Empirical Study on Islamic Banking显示文摘 | Tugiantoro Suyanto | 2014 | China-USA Business Review2014，13，5： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员